Acanthosis nigricans: metabolic interrelations inherent to the polycystic ovary syndrome

被引:2
作者
de Avila, Marcio Augusto Pinto [1 ]
Borges, Lunna Perdigao [2 ]
Paez, Marina Silva [1 ]
Bruno, Ricardo Vasconcellos [1 ]
Nardi, Antonio Egidio [2 ,4 ]
de Pessoa, Ana Carolina Machado [3 ,5 ]
Palmeira, Evelyn de Souza [6 ]
机构
[1] Univ Fed Rio Janeiro, Fac Med, Dept Ginecol & Obstet, Rio De Janeiro, Brazil
[2] Univ Fed Rio Janeiro, Inst Med, Grad Estat, Rio De Janeiro, Brazil
[3] Univ Fed Rio Janeiro, Inst Med, Dept Metodos, Rio De Janeiro, Brazil
[4] Univ Fed Rio Janeiro, Inst Ginecol, Setor Ginecol Endocrina, Rio De Janeiro, Brazil
[5] Univ Fed Rio Janeiro, Dept Psiquiat, Rio De Janeiro, Brazil
[6] Univ Fed Rio Janeiro, Curso Grad Med, Rio De Janeiro, Brazil
来源
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA | 2014年 / 36卷 / 09期
关键词
Acanthosis nigricans; Polycystic ovary syndrome; Insulin resistance; Metabolic syndrome X; Obesity;
D O I
10.1590/SO100-720320140005078
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
PURPOSE: To establish the prevalence of acanthosis nigricans (AN) within the context of polycystic ovary syndrome (PCOS) and its associations with obesity, insulin resistance, insulinemia, and metabolic syndrome (MS). METHODS: A cross-sectional prospective study was conducted on 100 patients with PCOS diagnosed according to the Rotterdam Consensus (2003). The skin test included, in addition to the detection of the presence of AN, the presence of hirsutism (score >= 8) and acne. In addition to clinical and biochemical data, we investigated cardiovascular risk factors present in MS such as abdominal circumference, obesity, hypertension and HDL and triglyceride levels. Insulin resistance was determined by the HOMA-IR test. RESULTS: The prevalence of AN (53%) was significantly correlated with hirsutism (p=0.02), body mass index (p<0.01), basal insulinemia (p<0.01), (HOMA-IR) (p<0.01), and MS (p<0.01). The prevalence of MS reached 36% and was significantly associated only with AN (p<0.01). Although diabetes mellitus was absent, there was a significant association of altered HOMA-IR (p<0.01) with MS (p<5%) and AN (p<0.01). CONCLUSION: AN is part of the severe phenotypic profile of PCOS as an additional predictable sign of the risks of cardiovascular disease.
引用
收藏
页码:410 / 415
页数:6
相关论文
共 50 条
  • [21] Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome
    Krentowska, Anna
    Kowalska, Irina
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (01)
  • [22] Metabolic Syndrome in Polycystic Ovary Syndrome
    Pasquali, Renato
    METABOLIC SYNDROME CONSEQUENT TO ENDOCRINE DISORDERS, 2018, 49 : 114 - 130
  • [23] Polycystic ovary syndrome, adipose tissue and metabolic syndrome
    Delitala, Alessandro P.
    Capobianco, Giampiero
    Delitala, Giuseppe
    Cherchi, Pier Luigi
    Dessole, Salvatore
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 296 (03) : 405 - 419
  • [24] Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping
    Caserta, Donatella
    Adducchio, Gloria
    Picchia, Simona
    Ralli, Eleonora
    Matteucci, Eleonora
    Moscarini, Massimo
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (06) : 397 - 402
  • [25] Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome?
    Shah, D.
    Rasool, S.
    CLIMACTERIC, 2016, 19 (01) : 7 - 16
  • [26] Acanthosis nigricans predicts the clustering of metabolic syndrome components in Hispanic elementary school-aged children
    Kong, Alberta S.
    Vanderbloemen, Laura
    Skipper, Betty
    Leggott, John
    Sebesta, Emilie
    Glew, Robert
    Burge, Mark R.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2012, 25 (11-12) : 1095 - 1102
  • [27] Polycystic ovary syndrome, adipose tissue and metabolic syndrome
    Alessandro P. Delitala
    Giampiero Capobianco
    Giuseppe Delitala
    Pier Luigi Cherchi
    Salvatore Dessole
    Archives of Gynecology and Obstetrics, 2017, 296 : 405 - 419
  • [28] Polycystic ovary syndrome: an endocrine and metabolic disease
    Scarpitta, AM
    Sinagra, D
    GYNECOLOGICAL ENDOCRINOLOGY, 2000, 14 (05) : 392 - 395
  • [29] Metabolic role of hepassocin in polycystic ovary syndrome
    Coskun, E. inci
    Omma, T.
    Taskaldiran, I.
    Firat, S. N.
    Culha, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (11) : 5175 - 5183
  • [30] Clinical and metabolic features of polycystic ovary syndrome
    Li, Lin
    Yang, Dongzi
    Chen, Xiaoli
    Chen, Yaxiao
    Feng, Shuying
    Wang, Liangan
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2007, 97 (02) : 129 - 134